Antimalarials………….Arterolane from Ranbaxy « New Drug Approvals
Antimalarials………….Arterolane from Ranbaxy « New Drug Approvals: 'via Blog this'
View ArticleMore and more companies are using fragment-based lead design as a drug...
More and more companies are using fragment-based lead design as a drug discovery strategy » All About Drugs: 'via Blog this'
View ArticleNovel Diacylglycerol Acyltransferase-1 (DGAT-1)...
Novel Diacylglycerol Acyltransferase-1 (DGAT-1) Inhibitor..1-(4-(4-Amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclobutanecarbonitrile « New Drug Approvals: 'via Blog this'
View ArticleFDA Approves Cyramza, ramucirumab (IMC-1121B) for Stomach Cancer « New Drug...
FDA Approves Cyramza, ramucirumab (IMC-1121B) for Stomach Cancer « New Drug Approvals: 'via Blog this'
View ArticleCobimetinib in phase 3 for metastatic melanoma « New Drug Approvals
Cobimetinib in phase 3 for metastatic melanoma « New Drug Approvals: 'via Blog this'
View ArticleFor many older men, impotence is treatable without drugs | lyranara.me
For many older men, impotence is treatable without drugs | lyranara.me: 'via Blog this'
View ArticleRG 7388 is a MDM2 inhibitor with superior potency and selectivity in phase 1...
RG 7388 is a MDM2 inhibitor with superior potency and selectivity in phase 1 trials « New Drug Approvals: 'via Blog this'
View ArticleBinimetinib in phase 3 for for the treatment of metastatic or unresectable...
Binimetinib in phase 3 for for the treatment of metastatic or unresectable cutaneous melanoma with NRAS mutations and in combination with LGX-818 in adult patients with BRAF V600 « New Drug Approvals:...
View ArticleTafenoquine…..GSK Launches Phase 3 Malaria Drug Trials « New Drug Approvals
Tafenoquine…..GSK Launches Phase 3 Malaria Drug Trials « New Drug Approvals: 'via Blog this'
View ArticleDASABUVIR, ABT 333 for the chronic Hepatitis C treatment. « New Drug Approvals
DASABUVIR, ABT 333 for the chronic Hepatitis C treatment. « New Drug Approvals: 'via Blog this'
View ArticleRucaparib, PF-01367338 for the treatment of patients with advanced ovarian...
Rucaparib, PF-01367338 for the treatment of patients with advanced ovarian cancer and in patients with locally advanced or metastatic breast cancer. « New Drug Approvals: 'via Blog this'
View ArticleMANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma...
MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: BIOSIMILARS MARKET IS NOT EQUIVALENT TO GENERICS M...: BIOSIMILARS MARKET IS NOT EQUIVALENT TO GENERICS...
View ArticleMANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma...
MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: BIOTECH IPOs: WHAT ENTREPRENEURS CAN LEARN FROM A ...: BIOTECH IPOs: WHAT ENTREPRENEURS CAN LEARN FROM A...
View ArticleMANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma...
MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: PHARMA DEALS DURING MARCH 2014Following on from l...: PHARMA DEALS DURING MARCH 2014 Following on from last...
View ArticleClik here to view.
Monoclonal Antibody Shows Promise in Childhood Brain Tumor
Tumors shrank or disappeared in some patients with advanced neuroblastoma in a Phase 1 study of an immune therapy manufactured at St. Jude Children's Research Hospital. Tumors shrank or disappeared and...
View ArticleTie up with Emcure…..Roche to launch cheaper cancer drugs in India « New Drug...
Tie up with Emcure…..Roche to launch cheaper cancer drugs in India « New Drug Approvals: 'via Blog this'
View ArticleShire signs monoclonal antibody agreement with arGEN-X
Shire signs monoclonal antibody agreement with arGEN-XShire Pharmaceuticals and arGEN-X, a Dutch clinical-stage biopharmaceutical company focused on developing therapeutic antibodies for the treatment...
View ArticleClik here to view.
Tackling Taxol
Tackling TaxolAn efficient synthesis of the tricyclic core of Taxol has been developedRead more
View ArticleClik here to view.
New method for uncovering side effects before a drug hits the market
New method for uncovering side effects before a drug hits the market http://www.sciencedaily.com/releases/2013/01/130102140516.htmSide effects are a major reason that drugs are taken off the market...
View Article